We are live on ! Find out more
SGHT icon

Sight Sciences

111 hedge funds and large institutions have $155M invested in Sight Sciences in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,800% more call options, than puts

Call options by funds: $297K | Put options by funds: $3K

500% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 6

116% more capital invested

Capital invested by funds: $71.8M → $155M (+$83M)

32% more funds holding

Funds holding: 84111 (+27)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

2.92% less ownership

Funds ownership: 39.89%36.97% (-2.9%)

Holders
111
Holders Change
+27
Holders Change %
+32.14%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
36
Increased
29
Reduced
29
Closed
6
Calls
$297K
Puts
$3K
Net Calls
+$294K
Net Calls Change
+$294K
Name Holding Trade Value Shares
Change
Change in
Stake
LFCM
1
Long Focus Capital Management
Puerto Rico
$26.1M +$634K +99,176 +3%
BlackRock
2
BlackRock
New York
$21.2M +$841K +131,689 +5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$15.5M +$268K +41,951 +2%
AP
4
Americana Partners
Texas
$10.9M +$953K +149,161 +12%
BGI
5
B Group Inc
Texas
$7.3M -$63.9K -10,000 -1%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$6.99M +$178K +27,802 +3%
State Street
7
State Street
Massachusetts
$5.85M +$469K +73,362 +11%
Pathstone Holdings
8
Pathstone Holdings
New Jersey
$5.7M +$4.59M +718,352 New
AMH
9
Apollo Management Holdings
New York
$4.05M -$1.03M -160,466 -24%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$3.99M +$174K +27,302 +6%
IHAM
11
Integral Health Asset Management
New York
$3.37M +$2.71M +425,000 New
Invesco
12
Invesco
Georgia
$2.79M +$2.25M +352,005 New
Northern Trust
13
Northern Trust
Illinois
$2.57M -$102K -15,936 -5%
Bank of America
14
Bank of America
North Carolina
$2.43M +$1.29M +202,210 +195%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$2.39M -$14.7K -2,299 -0.8%
Walleye Capital
16
Walleye Capital
New York
$2.33M +$1.88M +294,112 New
Charles Schwab
17
Charles Schwab
California
$2.29M +$81.5K +12,760 +5%
Renaissance Technologies
18
Renaissance Technologies
New York
$2.19M -$638K -99,900 -27%
Millennium Management
19
Millennium Management
New York
$2.12M +$850K +133,073 +99%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$1.85M +$119K +18,646 +9%
Morgan Stanley
21
Morgan Stanley
New York
$1.82M -$310K -48,480 -17%
EI
22
EAM Investors
California
$1.3M +$1.05M +163,866 New
Goldman Sachs
23
Goldman Sachs
New York
$1.26M +$322K +50,388 +47%
UBS Group
24
UBS Group
Switzerland
$1.18M +$443K +69,406 +88%
Citadel Advisors
25
Citadel Advisors
Florida
$1.17M +$944K +147,838 New

SGHT Hedge Fund Activity: Q4 2025 in Review

111 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Sight Sciences (SGHT) for Q4 2025, worth a combined $155M — up 116% from $71.8M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new SGHT positions and 6 closed out — a net gain of 30 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was Pathstone Holdings, opening a new position worth an estimated $4.59M. The largest seller was Prosight Management, exiting entirely with an estimated $1.51M sold.

  • 111 institutional investors held Sight Sciences (SGHT) as of Q4 2025, up from 84 in Q3 2025.
  • Funds reported $155M of Sight Sciences stock for Q4 2025, up 116% quarter-over-quarter.
  • 36 funds opened new Sight Sciences positions in Q4 2025 and 6 closed out, a net change of +30 holders.
  • The largest Sight Sciences buyer in Q4 2025 was Pathstone Holdings, an estimated $4.59M added.
  • The largest Sight Sciences seller in Q4 2025 was Prosight Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q4 2025.